EPINEX DIABETES BLOG

Stress hyperglycemia, or “stress diabetes,” is a condition that causes temporarily elevated blood glucose during recovery after a heart attack or stroke, even for non-diabetic patients. The American Heart Association recently posted an article entitled, “Another risk identified from ‘stress diabetes’ – and a possible new way to measure it”. It is based on a recent article published in the journal ‘Stroke AHA,’ reporting on a study conducted on 3026 patients. In these patients

A recent review article written by Epinex’s staff and published by Springer-Nature Journal “Inflammation Research’ 2017, highlights the utility of GA measurement both as mediator of inflammation as well as a marker to track hyperglycemia and other diabetic complications. This review shows an association of glycated albumin with inflammation and other diabetic complication like atherosclerosis, diabetic retinopathy, nephropathy (CKD) and rheumatoid arthritis. The review outlin

Epinex attended the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, which took place July 30 through August 3 2017 at the San Diego convention center. One of the highlights of this expo was the “Beyond Hemoglobin A1c” symposium that took place in the afternoon of August 1. Close to 200 attendees were at this symposium, where three speakers; David Sacks, Cyrus Desouza, and Paul J. Thornalley, discussed the challenges associated with Hemoglobin A1c (HbA1c) and explored

A recent review article in Critical Reviews in Clinical Laboratory Sciences analyzes glycemic control indicators such as hemoglobin A1c (HbA1c), glycated albumin (GA), and GA/HbA1c ratio. This article concludes that it is important to be able to select an appropriate glycated protein depending on each patient’s health status. Reports indicate that HbA1c is not always a suitable glycemic indicator even though it “is one of the most important diagnostic factors for diabetes” Co

The Journal of the American Medical Association recently published an article that analyzed the effectiveness of hemoglobin A1c (HbA1c) as a measure of diabetes outcomes. Lead researchers Dr. Kasia Lipska, MD and Dr. Harlan Krumholz, MD concluded that “treatment should be selected to target specific complications and inherent risks, not solely glucose levels.” Therefore, the authors suggest an alternative view that recommends identifying drugs for diabetes care based on outco

Clinical Chemistry and Laboratory Medicine (CCLM) recently published an analysis of hemoglobin A1c (HbA1c) and glycated albumin (GA) as effective glycemic markers. This study, led by Dr. Roberto Testa, MD of INRCA-IRCCS National Institute concluded that GA% (GA on total albumin ratio) is a useful indicator for diabetes management and monitoring where HbA1c is limited. As summarized in the article, several past studies support the potential for GA to be an overall marker for d

"To investigate whether glycated albumin is a useful glycemic marker from the point of view of infant complications for monitoring glycemic control in pregnant women with diabetes or gestational diabetes mellitus." Click here to read the full article Source- http://www.sciencedirect.com/science/article/pii/S1875957216300213 http://www.epinex.com/#!glycated-albumin/yrxvx #GestationalDiabetes #Type2diabetes #news #glycatedalbumin #GlycatedAlbumin #GlycatedAlbuminTest #glycatedh

"Although glucose level is the contributing factor and diagnostic marker for type 2 diabetes, there is an imperative need to look “beyond glucose” and to seek additional biomarkers that could better predict the risk for diabetes as well its diagnosis with accurate precision. Human serum albumin is one of the most abundant plasma proteins that readily undergoes glycation, thus glycated albumin has been suggested as an additional marker for monitoring glycemic status in people

"Measurements of fructosamine and glycated albumin could help identify people at risk of developing diabetes and diabetic complications such as retinopathy, with independent associations that are similar to the HbA1c test, new researchpublished online in Lancet Diabetes & Endocrinology suggests. This is the largest long-term study to evaluate these novel markers in relation to diabetes outcomes, offering important support to their potential value in a clinical setting." Click

"Albumin—the most abundant protein in the human body—has many roles. It transports hormones, fatty acids, and other compounds. It buffers serum pH, and maintains osmotic pressure. Now, it appears that albumin may be a tool that could be used in diabetes management. Researchers have published a description of glycated serum albumin’s potential role as a disease marker in the online version of Diabetes & Metabolic Syndrome." Click here to read the full article Source- http://w